Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. - Wikidata - wikimedia - TriplyDB

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.

http://www.wikidata.org/entity/Q37040827

about

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment Update on immune checkpoint inhibitors in gynecological cancers Defining the orphan functions of lysine acetyltransferases Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA)Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer ScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modeling Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.LNK (SH2B3): paradoxical effects in ovarian cancer.Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: a multidimensional analysis of the performance of reagents and workflows.HiTSelect: a comprehensive tool for high-complexity-pooled screen analysis Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers.Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes.The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer.Ovarian cancer stem cells: still an elusive entity?Ovarian cancer: diagnostic, biological and prognostic aspects.Systematic identification of barriers to human iPSC generation.The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.Frontline treatment of epithelial ovarian cancer.Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.New twists in the AXL(e) of tumor progression.Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.A single acetylation of 18 S rRNA is essential for biogenesis of the small ribosomal subunit in Saccharomyces cerevisiae.

P2860

Q27307642-F949A26D-D330-47B7-BA60-BA38E5374078 Q28066904-09236E07-C518-4084-AD2C-9D7E24204674 Q28076497-5D710064-8E2F-4984-9127-093778E3BC3D Q28083226-61A0B35D-4F3B-4190-B564-6A19B952CB7E Q28115130-64430DA6-3208-4074-A4FE-6D66F7013DF7 Q28553245-6E2B407A-5B40-46E7-9F0D-97FDD74809B7 Q28601274-B24EA908-2B19-4D4A-BE4A-EFDD2E4B5071 Q30919257-3CC534CA-F199-4686-884D-E8CD5CABF27B Q33564920-3A90383D-4491-492A-82ED-3D66A0B9C172 Q34007808-3624B033-E314-4B9F-B486-E8E84DEFBFAB Q34302585-AFB8916D-4BC7-4B9C-930D-2506C406FAD9 Q34880376-4D920597-6655-4360-B181-C4F54E51DEDA Q34988433-4D283E2F-A70C-4027-8545-FD1163A48BED Q35088920-454E8310-09B9-4726-86BA-FC7D12D4CC2B Q35328194-1CFC382F-7F23-4F8A-BA44-B92D80D9674D Q35671355-A25FDD2E-B68C-49FF-A673-E380FECD2EAE Q36057092-4EE12766-6553-4CF7-970D-FD291BA251AF Q36159864-0870AD54-A94F-486B-94B8-9EBF29DC9BD1 Q36355885-4AB9895C-4ACF-4F70-B28A-F1E1C7FF6B0B Q36544445-C838AFB0-71EC-49BF-86AC-873A5D3DDD64 Q36545609-B4290DD8-05DF-4B31-B906-834BE62E975B Q36591554-A890ACB9-6599-4A02-8E3B-6A7D178B751C Q36685525-13F1A4F6-3553-41C8-A140-B163FC2E328A Q36722186-753728A6-5BE8-4816-BFFE-073F39C1CAB8 Q37357076-C16CBBDB-36AB-4080-BC41-8C385A7DAAA7 Q37485636-E896F9EE-C8DF-46E0-8425-59CE65B2E9DC Q37631697-A0D18C10-D886-4295-A35C-B7DE5A49F9F4 Q37713683-FBD4B3E9-E45F-4029-BB3E-73737906CFD1 Q38261795-443F119D-C34A-4EE1-B927-32517C24FE60 Q38305710-47E4D364-71B6-44EC-A7ED-D906F2B3B4A2 Q38635932-A3E0519F-B90E-4853-A679-75D361615F69 Q38669746-883E1F1C-1464-41C7-923C-1F668643A71C Q38857163-155BD566-2942-425C-B4EF-4351D75F1DE7 Q38972265-980BBFDD-4A09-45C1-AD77-A35DC40C7580 Q39034224-DE75C6DC-7FAC-4CD5-B2D6-C9FB23988DEB Q41007816-039FB97C-0D35-40F4-A250-238E2F6D220E Q41585790-B037F94C-D477-4E11-9C34-FD0DC9F1AEE0 Q41611914-D50299C7-BCAD-4E7E-AB30-BB76417EA975 Q42276827-0EB87CFA-A7B2-4049-9667-2D0C4BE85732 Q42547174-E403A255-60E1-4C2B-8348-B040052580D4

P2860

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.

http://www.wikidata.org/entity/Q37040827

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional genomics identifies ...... in epithelial ovarian cancer.

@en

Functional genomics identifies ...... in epithelial ovarian cancer.

@nl

type

label

Functional genomics identifies ...... in epithelial ovarian cancer.

@en

Functional genomics identifies ...... in epithelial ovarian cancer.

@nl

prefLabel

Functional genomics identifies ...... in epithelial ovarian cancer.

@en

Functional genomics identifies ...... in epithelial ovarian cancer.

@nl

P1433

Q37040827-AA1C5469-DAA6-40D5-96F8-E393F157CE4B

P1476

Q37040827-0A25344C-3B39-499B-A375-0A161D322179

P2093

Q37040827-006B3D06-518A-4EEE-BF90-549687146113

Q37040827-153D137E-D204-4279-B0AD-76C02D1C4EBD

Q37040827-291E92C9-A96E-4EC0-988C-641EBBFA23B1

Q37040827-47045ED0-E057-411E-8C89-7C926250B7A9

Q37040827-50B2A6E0-6E99-4DA7-99F3-AF25D8BDC966

Q37040827-55FC97C3-9F89-468E-A02E-E7B3FA70638F

Q37040827-868A0384-F417-4379-AF05-DF59A356A3E6

Q37040827-8D0CDEE3-BF71-4356-B9E6-D3EEAAE5365E

Q37040827-975FD14F-341C-4CF9-B52E-8D6C3EF2FB2A

Q37040827-A0002721-45FC-4704-9BC5-106A49AD38EC

P2860

Q37040827-045413C2-7C4E-4372-B1B3-6A5D8BBEF750

Q37040827-14450183-FF89-4107-8639-92D51AC25AD2

Q37040827-17915919-02E7-45FC-8AD7-11DB02205434

Q37040827-211E2337-64B1-490C-8FDE-E2132C2AB5DF

Q37040827-2156501F-66C4-43CE-A75A-F1EF3D27840C

Q37040827-23658D28-AA1F-4311-8919-051ADED8ED1D

Q37040827-26306FE2-0A54-4A5B-BC41-63F76D3BBACC

Q37040827-2A94F685-9547-4FDB-BE66-018161E68532

Q37040827-2AF8187B-A40F-498D-B34D-AAC3243C645D

Q37040827-2DF64A7A-F1FC-43AC-AF64-D6C4347EB9D5

P304

Q37040827-2F437EFF-DBFA-427E-A91D-4677744A6A3C

P31

Q37040827-11DB3FFF-8C6F-4BEC-8115-2383910B1041

P356

Q37040827-89A78AF5-8549-48D4-9DC9-BD77F69C3790

P433

Q37040827-069E87C7-9410-412E-B0D7-0A836A2EBDA0

P478

Q37040827-3F11B65E-19A8-4112-B4CD-F3181A6E6DD2

P50

Q37040827-A7D66182-DC99-4886-8C47-04FED2FD5B9A

P577

Q37040827-9C4B8C95-9AF5-4377-90D5-76CAD76B3030

P5875

Q37040827-3A48D072-CF94-4370-84CE-A4D9BC97F6AD

P698

Q37040827-012DCEEB-6BAE-4A1A-9F50-8250E0EEEE8D

P921

Q37040827-B598BFE5-2288-411B-886A-628BAAB4E636

P932

Q37040827-5FE53396-73D3-4EFA-8BCE-FA053D9B6403

P356

P1433

EMBO Molecular Medicine

P1476

Functional genomics identifies ...... in epithelial ovarian cancer.

@en

P2093

Ben Davidson

http://www.w3.org/2001/XMLSchema#string

Boon-Cher Goh

http://www.w3.org/2001/XMLSchema#string

Ikuo Konishi

http://www.w3.org/2001/XMLSchema#string

Jean Paul Thiery

http://www.w3.org/2001/XMLSchema#string

Jeffrey T Chang

http://www.w3.org/2001/XMLSchema#string

Jieru Ye

http://www.w3.org/2001/XMLSchema#string

Jieying Amelia Lau

http://www.w3.org/2001/XMLSchema#string

Ling-Zhi Wang

http://www.w3.org/2001/XMLSchema#string

Luqman Hakim Bin Abdul Hadi

http://www.w3.org/2001/XMLSchema#string

Mahesh Choolani

http://www.w3.org/2001/XMLSchema#string

P2860

Human 76p: A new member of the gamma-tubulin-associated protein family

HDAC6 is a microtubule-associated deacetylase

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Integrated genomic analyses of ovarian carcinoma

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

affy--analysis of Affymetrix GeneChip data at the probe level

P304

1051-1066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201201823

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Jahn M. Nesland

P577

2013-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236692555

http://www.w3.org/2001/XMLSchema#string

P698

23666744

http://www.w3.org/2001/XMLSchema#string

P921

P932

3721473

http://www.w3.org/2001/XMLSchema#string